Long term outcome after intracoronary β radiation therapy

Heart

Volumn 91, Issue 7, 2005, Pages 942-947

  Sianos, Georgios ^a   Hoye, A ^a   Saia, F ^a   Van Der Giessen, W ^a   Lemos, P ^a   De Feyter, P J ^a   Levendag, P C ^a   Van Domburg, R ^a   Serruys, P W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD VESSEL OCCLUSION; BRACHYTHERAPY; CORONARY ARTERY BYPASS SURGERY; DEATH; ELECTRON THERAPY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR ADVERSE CARDIAC EVENTS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RESTENOSIS; RETROSPECTIVE STUDY; REVASCULARIZATION; SURVIVAL; TARGET LESION REVASCULARIZATION;

BETA RAYS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RADIOTHERAPY DOSAGE; RETREATMENT; RETROSPECTIVE STUDIES; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 21044433890     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.038026     Document Type: Article

References (26)

1. Teirstein PS, Massullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
2. Waksman R, White RL, Chan RC, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-71.
3. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
4. Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101:1895-8.
5. Popma JJ, Suntharalingam M, Lonsky AJ, et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-6.
6. Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta-radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial. Lancet 2002;359:551-7.
7. Verin V, Popowski Y, de Bruyne B, et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001;344:243-9.
8. Serruys PW, Sianos G, van der Giessen W, et al. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting: the beta-radiation in Europe (BRIE) study. Eur Heart J 2002;23:1351-9.
9. Kuntz R, Speiser B, Joyal M, et al. Clinical and angiographic outcomes after use of Sr-90 beta-radiation for the treatment of de novo and restenotic coronary lesions. Congress of the American College of Cardiology, Orlando, March, 2001.
10. Kaluza GL, Raizner AE, Mazur W, et al. Long-term effects of intracoronary beta-radiation in balloon- and stent-injured porcine coronary arteries. Circulation 2001;103:2108-13.
11. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101:360-5.
12. Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002;105:2737-40.
13. Ajani AE, Waksman R, Sharma AK, et al. Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: original WRIST. Washington radiation for in-stent restenosis trial. Cardiovasc Radiat Med 2001;2:200-4.
14. Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000;36:65-8.
15. Meerkin D, Joyal M, Tardif JC, et al. Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty. Circulation 2002;106:539-43.
16. Waksman R, Ajani AE, White RL, et al. Two-year follow-up after beta and gamma intracoronary radiation therapy for patients with diffuse in-stent restenosis. Am J Cardiol 2001;88:425-8.
17. Kiemeneij F, Serruys PW, Macaya C, et al. Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol 2001;37:1598-603.
18. Kimura T, Abe K, Shizuta S, et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 2002;105:2986-91.
19. Laham RJ, Carrozza JP, Berger C, et al. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol 1996;28:820-6.
20. Waksman R, Cheneau E, Ajani AE, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions, results of the Washington radiation for in-stent restenosis trial for long lesions (long WRIST) studies. Circulation 2003;107:1744-9.
21. Condado JA, Waksman R, Saucedo JF, et al. Five-year clinical and angiographic follow-up after intracoronary iridium-192 radiation therapy. Cardiovasc Radiat Med 2002;3:74-81.
22. Waksman R, Ajani AE, Pinnow E, et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington radiation for in-stent restenosis trial (WRIST) 12 versus WRIST PLUS. Circulation 2002;106:776-8.
23. Waksman R, Ajani AE, White RL, et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001;103:2332-5.
24. Costa MA, Sabate M, van der Giessen, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100:789-92.
25. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
26. Degertekin M, Serruys PW, Foley DP, et al. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up. Circulation 2002;106:1610-3.